Dextromethorphan

Back to search

Molecule Structure

Scientific Name

Dextromethorphan

Description of the Drug

Dextromethorphan is an NMDA receptor antagonist used to treat cases of dry cough.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00514

Brand Name(s)

Not Available

Company Owner(s)

Alkem Laboratories Ltd, Eywa Pharma Inc, Halsey Drug Co Inc, Rhodes Pharmaceuticals Lp, Amneal Pharmaceuticals Of New York Llc, Amneal Pharmaceuticals Llc, Akorn Operating Co Llc, Actavis Laboratories Fl Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc, Chartwell Molecular Holdings Llc, Perrigo R And D Co

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Sigma opioid receptor SINGLE PROTEIN AGONIST CHEMBL287
Glutamate [NMDA] receptor subunit epsilon 1 SINGLE PROTEIN ANTAGONIST CHEMBL1972

Unichem Links

SureChEMBL SCHEMBL29949
PharmGKB PA449273
DrugBank DB00514
PubChem: Thomson Pharma 14750569 15197408
PubChem 5360696
LINCS LSM-2726
BindingDB 50366613
EPA CompTox Dashboard DTXSID3022908
DrugCentral 842
Metabolights MTBLC4470 MTBLC92579
Brenda 24585
Guide to Pharmacology 6953
rxnorm DEXTROMETHORPHAN HYDROBROMIDE DELSYM DEXTROMETHORPHAN DEXTROMETHORPHAN POLISTIREX
ChEBI 4470
ZINC ZINC000003201907